What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Blue Collar Picks
Big buy
$26.4M open-market purchase by Felix Baker, Director at Kymera Therapeutics,Inc., filed June 30, 2025. Learn more
What this is
This page shows the rows from one Form 4 filing as reported to the SEC.
Why it matters
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Felix Baker · Director at Kymera Therapeutics,Inc.
Felix Baker bought $26.4M of KYMR (Kymera Therapeutics,Inc.).
Insider purchase
Felix Baker, a Director, reported a $26.4M open-market purchase equal to 0.31% of KYMR's market cap.
Felix Baker (Director) bought 600,309 shares of KYMR, Kymera Therapeutics,Inc., Healthcare ($8.51B market cap), at $44.00 per share on June 30, 2025 for a total of $26.4M (0.31% of the market cap).
Felix Baker
Director
Permalink https://bluecollarpicks.com/insider-trading/KYMR/buy/14383
Market context
Last enriched August 11, 2026 at 8:07 AM EDT.
Filings
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
| This filing | Cluster Buy Director | $26.4M | |
Grant Officer | $0 | ||
Sell Director | $4.5M | ||
Sell Director | $123.5K | ||
Grant Director | $0 | ||
Sell Director | $1.9M | ||
Exercise and Hold Director | $234.8K | ||
Exercise and Hold Officer | $52.6K | ||
Exercise and Hold CFO | $26.3K | ||
Sell Officer | $292.3K | ||
Exercise and Hold CFO | $31.2K | ||
Sell Director | $1.1K | ||
Sell Director | $7.9K | ||
Exercise and Hold Director | $5.2K | ||
Exercise and Hold Director | Not reported | ||
Exercise and Hold Director | $80K | ||
Exercise and Hold Director | Not reported | ||
Sell Director | $530.8K | ||
Exercise and Hold Officer | $3K | ||
Exercise and Hold Officer | $8.7K | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold Officer | Not reported | ||
Sell Officer | $27K | ||
Sell Officer | $121.2K | ||
Exercise and Hold Officer | $56.5K | ||
Sell Officer | $117K | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold Officer | $34.1K | ||
Exercise and Hold Officer | Not reported | ||
Exercise and Hold Officer | $134.7K | ||
Sell Officer | $472.6K | ||
Exercise and Hold Officer | Not reported | ||
Sell Director | $34.7K | ||
Exercise and Hold Director | $31.2K | ||
Sell Director | $197.9K | ||
Exercise and Hold Director | Not reported | ||
Sell Director | $247.8K | ||
Exercise and Hold Director | $59K | ||
Sell Director | $374.2K | ||
Exercise and Hold Director | Not reported | ||
Sell Officer | $174.7K | ||
Exercise and Hold Officer | $52.6K | ||
Exercise and Hold Officer | Not reported | ||
Sell Officer | $232.6K | ||
Sell Officer | $268K | ||
Sell Officer | $222.5K | ||
| $94.7K | |||
| $1.2M | |||
| $433.9K | |||
| $289.7K | |||
| $65.2K | |||
Selected filing
Select a row to inspect the filing.
Cluster detail
Ticker context
Recent insider activity for this company.
Insider detail
Recent transactions grouped by reporting owner.
Filters
Weekly recap
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.